Login / Signup

Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma.

Alexandros RampotasGavinda SanghaGraham P Collins
Published in: Therapeutic advances in hematology (2021)
Keyphrases
  • diffuse large b cell lymphoma
  • epstein barr virus
  • single cell
  • acute lymphoblastic leukemia
  • cell therapy
  • stem cells
  • combination therapy
  • multiple myeloma
  • replacement therapy